                               SEQUENCE LISTING

<110> ANTIGEN EXPRESS, INC.

<120> HUMAN PAPILLOMAVIRUS / LI-KEY HYBRIDS AND METHODS OF USE

<130> AEX-2006WO02

<140> PCT/US2009/055608
<141> 2009-09-01

<150> 61/169,908
<151> 2009-04-16

<150> 61/093,606
<151> 2008-09-02

<160> 20    

<170> PatentIn version 3.5

<210> 1
<211> 30
<212> PRT
<213> Human papillomavirus type 16

<400> 1
Met His Gly Asp Thr Pro Thr Leu His Glu Tyr Met Leu Asp Leu Gln 
1               5                   10                  15      


Pro Glu Thr Thr Asp Leu Tyr Cys Tyr Glu Gln Leu Asn Asp 
            20                  25                  30  


<210> 2
<211> 19
<212> PRT
<213> Human papillomavirus type 16

<400> 2
Leu His Glu Tyr Met Leu Asp Leu Gln Pro Glu Thr Thr Asp Leu Tyr 
1               5                   10                  15      


Cys Tyr Glu 
            


<210> 3
<211> 15
<212> PRT
<213> Human papillomavirus type 16

<400> 3
Leu His Glu Tyr Met Leu Asp Leu Gln Pro Glu Thr Thr Asp Leu 
1               5                   10                  15  


<210> 4
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic peptide


<220>
<221> MOD_RES
<222> (5)..(5)
<223> 5-aminovaleric acid

<400> 4
Leu Arg Met Lys Xaa Leu His Glu Tyr Met Leu Asp Leu Gln Pro Glu 
1               5                   10                  15      


Thr Thr Asp Leu 
            20  


<210> 5
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic peptide


<220>
<221> MOD_RES
<222> (5)..(5)
<223> 5-aminovaleric acid

<400> 5
Leu Arg Met Lys Xaa His Glu Tyr Met Leu Asp Leu Gln Pro Glu Thr 
1               5                   10                  15      


Thr Asp Leu 
            


<210> 6
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic peptide


<220>
<221> MOD_RES
<222> (5)..(5)
<223> 5-aminovaleric acid

<400> 6
Leu Arg Met Lys Xaa Glu Tyr Met Leu Asp Leu Gln Pro Glu Thr Thr 
1               5                   10                  15      


Asp Leu 
        


<210> 7
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic peptide


<220>
<221> MOD_RES
<222> (5)..(5)
<223> 5-aminovaleric acid

<400> 7
Leu Arg Met Lys Xaa Tyr Met Leu Asp Leu Gln Pro Glu Thr Thr Asp 
1               5                   10                  15      


Leu 
    


<210> 8
<211> 10
<212> PRT
<213> Human papillomavirus type 16

<400> 8
Tyr Met Leu Asp Leu Gln Pro Glu Thr Thr 
1               5                   10  


<210> 9
<211> 16
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: Mammalian li-key peptide

<400> 9
Leu Arg Met Lys Leu Pro Lys Pro Pro Lys Pro Val Ser Lys Met Arg 
1               5                   10                  15      


<210> 10
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic peptide

<400> 10
Tyr Arg Met Lys Leu Pro Lys Pro Pro Lys Pro Val Ser Lys Met Arg 
1               5                   10                  15      


<210> 11
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic peptide

<400> 11
Leu Arg Met Lys 
1               


<210> 12
<211> 26
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic peptide

<400> 12
Leu His Glu Tyr Met Leu Asp Leu Gln Pro Glu Thr Thr Asp Leu Gly 
1               5                   10                  15      


Gly Tyr Pro Tyr Asp Val Pro Asp Tyr Ala 
            20                  25      


<210> 13
<211> 29
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic peptide


<220>
<221> MOD_RES
<222> (5)..(5)
<223> 5-aminovaleric acid

<400> 13
Leu Arg Met Lys Xaa Glu Tyr Met Leu Asp Leu Gln Pro Glu Thr Thr 
1               5                   10                  15      


Asp Leu Gly Gly Tyr Pro Tyr Asp Val Pro Asp Tyr Ala 
            20                  25                  


<210> 14
<211> 9
<212> PRT
<213> Human papillomavirus type 16

<400> 14
Arg Ala His Tyr Asn Ile Val Thr Phe 
1               5                   


<210> 15
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic peptide

<400> 15
Tyr Pro Tyr Asp Val Pro Asp Tyr Ala 
1               5                   


<210> 16
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic peptide

<400> 16
Tyr Arg Met Lys 
1       

        
<210> 17
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic peptide

<400> 17
Leu Arg Met Lys Leu Pro Lys 
1               5           


<210> 18
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic peptide

<400> 18
Leu Arg Met Lys Leu Pro Lys Ser 
1               5               


<210> 19
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic peptide

<400> 19
Leu Arg Met Lys Leu Pro Lys Ser Ala Lys Pro 
1               5                   10      


<210> 20
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic peptide

<400> 20
Leu Arg Met Lys Leu Pro Lys Ser Ala Lys Pro Val Ser Lys 
1               5                   10                  



